Latest news

NICE has today confirmed that it has not recommended Abraxane for use by the NHS in England for patients with metastatic pancreatic cancer, on cost grounds. This decision will also affect patients in Northern Ireland.

We are delighted to announce our collaboration with Scotland’s Chief Scientist Office (CSO) to fund research into pancreatic cancer. The CSO will offer joint funding with Pancreatic Cancer UK to fund two Scottish projects of up to £75,000 each through our Research Innovation Fund (RIF). 

A specialist nurse at leading cancer centre, The Christie NHS Foundation Trust in Manchester, has been recognised for her work with pancreatic cancer patients.

The results of a study by a team at University College London (UCL) published today in BMG Open, indicate that symptom-based cancer decision support tools are useful in identifying pancreatic ductal adenocarcinoma (PDAC) and biliary tract cancers (BTC) at an early stage.

Today the APPG on Pancreatic Cancer launches its vital research report